Patent Term Extensions for Software Products: What They Are and When They Apply

A granted utility patent gives you twenty years from your earliest effective filing date — not from the grant date, and not from the date you launched your product. For most software and e-commerce companies, that statutory term is what you get. But there are mechanisms that can adjust patent term in either direction, and misunderstanding them leads founders to either overestimate how long their protection lasts or miss a legitimate opportunity to recover time they lost during prosecution.

The Basic Twenty-Year Rule

The twenty-year clock starts on the date you file your nonprovisional application, or on the date of the earliest nonprovisional application in a chain of priority if you filed continuations or divisionals. A provisional application does not start the clock — but it also does not stop it. If you file a provisional, wait twelve months, then file your nonprovisional, you have effectively used one year of your patent term before prosecution even begins. That is a real cost that many first-time applicants do not appreciate until later.

The practical implication: the longer prosecution drags on — office actions, appeals, examiner interviews, amendments — the shorter your remaining enforceable term when the patent finally issues. A software patent that takes four years to prosecute and issues with sixteen years remaining has a meaningfully shorter commercial life than one that issues in eighteen months.

Patent Term Adjustment: The Mechanism That Actually Helps Software Applicants

Patent Term Adjustment, commonly called PTA, is the one term-extension mechanism that regularly applies to software and internet patents. Under 35 U.S.C. § 154, the USPTO is required to act within certain deadlines during prosecution. When it fails to meet those deadlines — for example, by taking more than fourteen months to issue a first office action, or more than four months to respond to an applicant's reply — the USPTO accrues a day-for-day obligation to add time to your patent term at issuance.

How PTA Is Calculated

The USPTO tracks three categories of delay: A-delay (USPTO failing to meet examination deadlines), B-delay (prosecution running longer than three years from filing), and C-delay (time consumed by appeals or interferences). These are added together, then reduced by any applicant delay — meaning days you took beyond the permitted response windows to reply to an office action or pay a fee.

The final PTA number appears on the face of your issued patent. It is not optional or discretionary; the USPTO computes it automatically. However, the calculation is not always correct, and applicants have the right to petition for a recalculation if they believe the USPTO made an error. This is a narrow, technical process with short deadlines, and most applicants do not pursue it — but it exists.

What PTA Does Not Fix

PTA compensates for government delay, not for time consumed by the applicant's own prosecution choices. If you filed a continuation to pursue broader claims, the continuation's clock starts fresh on its own filing date. PTA does not transfer across applications. Each application stands alone.

Patent Term Extension: The Pharmaceutical Carveout That Does Not Apply to Software

Patent Term Extension under 35 U.S.C. § 156 is a separate and entirely different mechanism. It was designed for pharmaceutical and medical device products that require premarket regulatory approval from the FDA before they can be sold. The time spent waiting for that approval can be partially recovered — up to five additional years — through this process.

Software products, mobile applications, e-commerce platforms, and internet services are not subject to FDA premarket approval. They do not qualify for § 156 extensions. Period. If you encounter a vendor or service claiming to extend your software patent's term through this mechanism, that claim is wrong.

Terminal Disclaimers and Term Reduction

Term can also move in the other direction. When the USPTO finds that two related applications claim inventions that are not patentably distinct — a rejection called obviousness-type double patenting — the applicant is typically required to file a terminal disclaimer. A terminal disclaimer voluntarily cuts a patent's term short, capping it so it expires no later than a commonly owned related patent. If you are building a patent family around a core software invention, terminal disclaimers in your continuation or divisional applications are common and expected. They do not invalidate your patent, but they do mean your family members will not outlive your original grant.

Practical Takeaways

• Your utility patent term is twenty years from your nonprovisional filing date, not from issuance — know the difference before you plan a licensing or enforcement strategy.
• Patent Term Adjustment compensates for USPTO delays during prosecution and is calculated automatically, but the number on your issued patent deserves a review.
• Applicant delay — slow responses to office actions — reduces PTA day for day, so response timing has real economic consequences.
• Patent Term Extension under § 156 applies only to FDA-regulated products; it has no application to software, apps, or internet services.
• Terminal disclaimers are routine in patent families but permanently cap the term of the disclaimed patent, which matters when you are projecting long-term portfolio value.
• If your software product has a long commercial runway, factor prosecution timeline into your filing strategy from the start rather than treating it as an afterthought.

This guide is general education, not legal advice, and does not create an attorney–client relationship. For your specific situation, talk to a registered patent attorney.